OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Public Statements

Office

Presidential Congressional Gubernatorial State Legislative Federal Judicial Statewide State Judicial

State

Alabama Alaska American Samoa Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana National Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Northern Mariana Islands Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming

Issue

All Issues Abortion Agriculture and Food Animals and Wildlife Arts, Entertainment, and History Budget, Spending and Taxes Business and Consumers Business, Consumers, and Employees Campaign Finance Civil Liberties and Civil Rights Conservative Constitution Criminal Justice Death Penalty Defense Drugs Economy and Fiscal Education Elections Employment and Affirmative Action Energy Entitlements and the Safety Net Environment Executive Branch Family Federal, State and Local Relations Finance and Banking Fiscally Conservative Fiscally Liberal Food Processing and Sales Foreign Affairs Foreign Aid Gambling and Gaming Government Budget and Spending Government Operations Guns Health Insurance Health and Health Care High Priority Higher Education Housing and Property Ideology Immigration Impartial/Nonpartisan Indigenous Peoples Industries Infrastructure Issues Judicial Branch K-12 Education Labor Unions Legal Legislative Branch Liberal Low Priority Marijuana Marriage Military Personnel Minors and Children Monetary Policy National Security Natural Resources Oil and Gas Populations Priorities Religion Reproduction Science Science, Technology and Communication Senior Citizens Sexual Orientation and Gender Identity Social Socially Conservative Socially Liberal Stem Cell Research Taxes Technology and Communication Trade Transportation Unemployed and Low-Income Veterans Women

Limit results to:

Date Range

Keyword Search

Search string must be longer than 3 characters.
Page 94 of 192
results per page:
75 50 25
Date Title Politician
Oct. 4, 2016 Grassley Presses EpiPen Maker, Federal Agency on Medicaid Classification Sen. Chuck Grassley
Sept. 30, 2016 The Conway Daily Sun - Ayotte and Hassan Spar in First Debate Sen. Maggie Hassan, ...
Sept. 30, 2016 Wyden, Booker, Gillibrand Express Concern about DEA Process to Schedule Kratom Sen. Kirsten Gillibrand, ...
Sept. 28, 2016 Legislative Branch Appropriations Act, 2017 Rep. Hal Rogers
Sept. 28, 2016 Press Release: Congressman Foster Introduces a Package of Bills to Improve Educational Opportunities and Affordability Rep. Bill Foster
Sept. 28, 2016 Congress Passes Continuing Resolution with Full Military Construction and Veterans Affairs Funding, and Resources to Address the Zika Virus, the Opioid Epidemic, and Flood Recovery Rep. Hal Rogers
Sept. 28, 2016 Wyden, Pallone Confirm EpiPen Makers Overcharged Medicaid for Two Decades Sen. Ron Wyden
Sept. 28, 2016 The Hill - Mylan CEO Should Be Ashamed of EpiPen Prices Rep. Glenn Grothman
Sept. 27, 2016 Letter to Mrs. Heather Bresch, CEO of Mylan, Inc. - Seeking Answers on Factors Contributing to Repeated Price Hikes Sen. Patty Murray
Sept. 27, 2016 WKTV - First 22nd Congressional District Debate Draws Big Crowd Rep. Claudia Tenney, ...
Sept. 27, 2016 Obamacare Sen. Shelley Capito
Sept. 27, 2016 Markey Calls on FTC to Fully Investigate Suboxone Drugmaker for Antitrust Violations Sen. Ed Markey
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep. Bobby Scott
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep. Steven Guthrie
Sept. 26, 2016 Press Release: Foster Hosts Science of Addiction Discussion Rep. Bill Foster
Sept. 26, 2016 Rogers Votes to Take Synthetic Drugs Off the Market Rep. Hal Rogers
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep. Jim Himes
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep. Buddy Carter
Sept. 23, 2016 Larson, Gov. Malloy: State Police Receive $1.5 Million Federal Grant to Expand Initiatives Combating Heroin and Opioid Abuse Rep. John Larson, ...
Sept. 22, 2016 Shaheen on Senate Floor: "We Need to Fund CARA" to Address the Opioid Epidemic Sen. Cynthia Shaheen
Sept. 22, 2016 Prescription Opioid and Heroin Epidemic Awareness Week Sen. Amy Klobuchar
Sept. 22, 2016 Shaheen Statement on the Lack of Opioid Funding in the Stop-gap Government Funding Measure Introduced by Republican Leadership Sen. Cynthia Shaheen
Sept. 22, 2016 Prescription Opioid and Heroin Epidemic Awareness Week Sen. Cynthia Shaheen
Sept. 22, 2016 Prescription Opioid and Heroin Epidemic Awareness Week Sen. Ed Markey
Sept. 22, 2016 Cotton Introduces the Safely Advancing Valuable and Inexpensive New Generic Solutions Act Sen. Tom Cotton
Sept. 22, 2016 Menendez, Booker Announce $1.2M COPS Grant to Battle NJ's Heroin, Prescription Opioid Crisis Sen. Cory Booker, ...
Sept. 22, 2016 Pallone Announces $1.3 Million DOJ Grant to Fight Opioid Epidemic in NJ Rep. Frank Pallone
Sept. 22, 2016 National Security, Health, and Safety Rep. Brendan Boyle
Sept. 22, 2016 Cramer: Health Bills Strengthen Response To Drug, Mental Health Issues Sen. Kevin Cramer
Sept. 21, 2016 Dixon Police Department Safe Passage Initiative Sen. Dick Durbin
Sept. 21, 2016 Legislative Branch Appropriations Act, 2017--Motion to Proceed-- Sen. Bernie Sanders
Sept. 21, 2016 Governor Hassan and Executive Council Approve Contracts to Expand Substance Misuse Services for Pregnant and Parenting Women, to Support Safe Stations Initiative, to Provide Family Support Services Sen. Maggie Hassan
Sept. 21, 2016 Hearing of the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee of the Senate Appropriations Committee - Opening Statement on 'Prioritizing Public Health: The FDA's Role in the Generic Drug Marketplace' Sen. Jerry Moran
Sept. 20, 2016 Congressman Darrell Issa Introduces Sober Living Homes Reform Bill Rep. Darrell Issa
Sept. 20, 2016 Rep. Castor Urges More Transparency With Price Hikes by Drug Manufacturers Rep. Kathy Castor
Sept. 20, 2016 Letter to the Honorable Daniel Levinson, Inspector General of the Dept. of Health and Human Services - Call for Review of Rebate Practices for Mylan's EpiPen Sen. Mike Crapo, ...
Sept. 20, 2016 Cotton Statement on the FDA's Accelerated Approval of an Important Muscular Dystrophy Drug Sen. Tom Cotton
Sept. 19, 2016 Chairman Johnson Applauds FDA Decision to Approve Eteplirsen To Treat Duchenne Muscular Dystrophy Sen. Ron Johnson
Sept. 16, 2016 Boozman, Cotton Support Ending Medicare Part D Retroactive Fees Sen. John Boozman, ...
Sept. 16, 2016 Congressman Garamendi Urges Congress to Scrutinize Proposed Bayer-Monsanto Merger Rep. John Garamendi
Sept. 16, 2016 Letter to the Honorable John Kerry, Secretary of the Dept. of State - Address Trafficking of Synthetic Drugs and Illicit Goods Through Mail Service Sen. Chuck Grassley, ...
Sept. 15, 2016 Baldwin, Mccain, Schakowsky Introduce Reform Requiring Transparency In Prescription Drug Price Increases Sen. Tammy Baldwin
Sept. 15, 2016 Addressing Critical Matters Facing Our Nation Sen. Jack Reed
Sept. 15, 2016 Opioid Epidemic Sen. Shelley Capito
Sept. 15, 2016 Tiberi and Neal Introduce STOP Act in the House to Address Overdose Spike From Synthetic Opioids Rep. Richard Neal, ...
Sept. 14, 2016 Bipartisan Group of Senators Respond to Report Showing that 20% of Medicare Generic Drugs Have More Than Doubled in Price Sen. Mark Warner
Sept. 14, 2016 Capito Co-sponsors New Legislation To Address Drug Supply In West Virginia Sen. Shelley Capito
Sept. 14, 2016 Getting Our Work Done Sen. Cynthia Shaheen
Sept. 14, 2016 Kaptur Pursues Opioid Treatment Funds Rep. Marcy Kaptur
Sept. 14, 2016 The Epidemic of Drug Use Rep. Ryan Zinke
Date Title Politician
Oct. 4, 2016 Grassley Presses EpiPen Maker, Federal Agency on Medicaid Classification Sen.Chuck Grassley
Sept. 30, 2016 The Conway Daily Sun - Ayotte and Hassan Spar in First Debate Sen.Maggie Hassan, ...
Sept. 30, 2016 Wyden, Booker, Gillibrand Express Concern about DEA Process to Schedule Kratom Sen.Kirsten Gillibrand, ...
Sept. 28, 2016 Legislative Branch Appropriations Act, 2017 Rep.Hal Rogers
Sept. 28, 2016 Press Release: Congressman Foster Introduces a Package of Bills to Improve Educational Opportunities and Affordability Rep.Bill Foster
Sept. 28, 2016 Congress Passes Continuing Resolution with Full Military Construction and Veterans Affairs Funding, and Resources to Address the Zika Virus, the Opioid Epidemic, and Flood Recovery Rep.Hal Rogers
Sept. 28, 2016 Wyden, Pallone Confirm EpiPen Makers Overcharged Medicaid for Two Decades Sen.Ron Wyden
Sept. 28, 2016 The Hill - Mylan CEO Should Be Ashamed of EpiPen Prices Rep.Glenn Grothman
Sept. 27, 2016 Letter to Mrs. Heather Bresch, CEO of Mylan, Inc. - Seeking Answers on Factors Contributing to Repeated Price Hikes Sen.Patty Murray
Sept. 27, 2016 WKTV - First 22nd Congressional District Debate Draws Big Crowd Rep.Claudia Tenney, ...
Sept. 27, 2016 Obamacare Sen.Shelley Capito
Sept. 27, 2016 Markey Calls on FTC to Fully Investigate Suboxone Drugmaker for Antitrust Violations Sen.Ed Markey
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep.Bobby Scott
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep.Steven Guthrie
Sept. 26, 2016 Press Release: Foster Hosts Science of Addiction Discussion Rep.Bill Foster
Sept. 26, 2016 Rogers Votes to Take Synthetic Drugs Off the Market Rep.Hal Rogers
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep.Jim Himes
Sept. 26, 2016 Dangerous Synthetic Drug Control Act of 2016 Rep.Buddy Carter
Sept. 23, 2016 Larson, Gov. Malloy: State Police Receive $1.5 Million Federal Grant to Expand Initiatives Combating Heroin and Opioid Abuse Rep.John Larson, ...
Sept. 22, 2016 Shaheen on Senate Floor: "We Need to Fund CARA" to Address the Opioid Epidemic Sen.Cynthia Shaheen
Sept. 22, 2016 Prescription Opioid and Heroin Epidemic Awareness Week Sen.Amy Klobuchar
Sept. 22, 2016 Shaheen Statement on the Lack of Opioid Funding in the Stop-gap Government Funding Measure Introduced by Republican Leadership Sen.Cynthia Shaheen
Sept. 22, 2016 Prescription Opioid and Heroin Epidemic Awareness Week Sen.Cynthia Shaheen
Sept. 22, 2016 Prescription Opioid and Heroin Epidemic Awareness Week Sen.Ed Markey
Sept. 22, 2016 Cotton Introduces the Safely Advancing Valuable and Inexpensive New Generic Solutions Act Sen.Tom Cotton
Sept. 22, 2016 Menendez, Booker Announce $1.2M COPS Grant to Battle NJ's Heroin, Prescription Opioid Crisis Sen.Cory Booker, ...
Sept. 22, 2016 Pallone Announces $1.3 Million DOJ Grant to Fight Opioid Epidemic in NJ Rep.Frank Pallone
Sept. 22, 2016 National Security, Health, and Safety Rep.Brendan Boyle
Sept. 22, 2016 Cramer: Health Bills Strengthen Response To Drug, Mental Health Issues Sen.Kevin Cramer
Sept. 21, 2016 Dixon Police Department Safe Passage Initiative Sen.Dick Durbin
Sept. 21, 2016 Legislative Branch Appropriations Act, 2017--Motion to Proceed-- Sen.Bernie Sanders
Sept. 21, 2016 Governor Hassan and Executive Council Approve Contracts to Expand Substance Misuse Services for Pregnant and Parenting Women, to Support Safe Stations Initiative, to Provide Family Support Services Sen.Maggie Hassan
Sept. 21, 2016 Hearing of the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee of the Senate Appropriations Committee - Opening Statement on 'Prioritizing Public Health: The FDA's Role in the Generic Drug Marketplace' Sen.Jerry Moran
Sept. 20, 2016 Congressman Darrell Issa Introduces Sober Living Homes Reform Bill Rep.Darrell Issa
Sept. 20, 2016 Rep. Castor Urges More Transparency With Price Hikes by Drug Manufacturers Rep.Kathy Castor
Sept. 20, 2016 Letter to the Honorable Daniel Levinson, Inspector General of the Dept. of Health and Human Services - Call for Review of Rebate Practices for Mylan's EpiPen Sen.Mike Crapo, ...
Sept. 20, 2016 Cotton Statement on the FDA's Accelerated Approval of an Important Muscular Dystrophy Drug Sen.Tom Cotton
Sept. 19, 2016 Chairman Johnson Applauds FDA Decision to Approve Eteplirsen To Treat Duchenne Muscular Dystrophy Sen.Ron Johnson
Sept. 16, 2016 Boozman, Cotton Support Ending Medicare Part D Retroactive Fees Sen.John Boozman, ...
Sept. 16, 2016 Congressman Garamendi Urges Congress to Scrutinize Proposed Bayer-Monsanto Merger Rep.John Garamendi
Sept. 16, 2016 Letter to the Honorable John Kerry, Secretary of the Dept. of State - Address Trafficking of Synthetic Drugs and Illicit Goods Through Mail Service Sen.Chuck Grassley, ...
Sept. 15, 2016 Baldwin, Mccain, Schakowsky Introduce Reform Requiring Transparency In Prescription Drug Price Increases Sen.Tammy Baldwin
Sept. 15, 2016 Addressing Critical Matters Facing Our Nation Sen.Jack Reed
Sept. 15, 2016 Opioid Epidemic Sen.Shelley Capito
Sept. 15, 2016 Tiberi and Neal Introduce STOP Act in the House to Address Overdose Spike From Synthetic Opioids Rep.Richard Neal, ...
Sept. 14, 2016 Bipartisan Group of Senators Respond to Report Showing that 20% of Medicare Generic Drugs Have More Than Doubled in Price Sen.Mark Warner
Sept. 14, 2016 Capito Co-sponsors New Legislation To Address Drug Supply In West Virginia Sen.Shelley Capito
Sept. 14, 2016 Getting Our Work Done Sen.Cynthia Shaheen
Sept. 14, 2016 Kaptur Pursues Opioid Treatment Funds Rep.Marcy Kaptur
Sept. 14, 2016 The Epidemic of Drug Use Rep.Ryan Zinke
Page 94 of 192
arrow_upward